Clinical Evaluation of Adjusted Doses of Darunavir/Ritonavir With Rifampicin in HIV-infected Volunteers
Condition: HIV Infections Interventions: Drug: Darunavir/ritonavir 800/100 mg tablet; Drug: Rifampicin 600mg QD tablet and DTG 50mg BD Sponsors: University of Cape Town; Wits Reproductive Health and HIV Institute; Desmond Tutu HIV Centre Terminated (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2019 Category: Research Source Type: clinical trials
Impact of Steady State Cobicistat and Darunavir/Cobicistat on the Pharmacokinetics and Pharmacodynamic of Oral Anticoagulants (Rivaroxaban, Apixaban) in Health Volunteers
Condition: Healthy Volunteers Interventions: Drug: Tybost (Cobicistat); Drug: Prezcobix (Darunavir/Cobicistat); Drug: Xarelto (Rivaroxaban); Drug: Eliquis (Apixaban) Sponsor: National Institutes of Health Clinical Center (CC) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2019 Category: Research Source Type: clinical trials